Water

Water

SCHEMBL6670447

CC(C)(C)OC(=O)NCC(=O)NCC(=O)O.O

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO

The experimentally established mechanism targets of Water. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 known ✓ O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
GAA P10253 1/20 0.45
TDP1 Q9NUW8 1/20 0.43
MAOA P21397 1/20 0.41
MAOB P27338 1/20 0.41
NPFFR1 Q9GZQ6 1/20 0.40
NPFFR2 Q9Y5X5 1/20 0.40
CTSS P25774 5/20 0.40
CTSK P43235 5/20 0.40
EGLN1 Q9GZT9 1/20 0.38
CTSL P07711 1/20 0.38
CTSB P07858 1/20 0.38
ALDH1A1 P00352 1/20 0.38
TSHR P16473 1/20 0.38
KDM4E B2RXH2 1/20 0.37
LMNA P02545 1/20 0.37
CA12 O43570 2/20 0.37
CA2 P00918 2/20 0.37
CA14 Q9ULX7 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1486144 0.98 MEN1 (0.46) MEN1KMT2AGAATDP1MAOA
SCHEMBL8500219 0.98 MEN1 (0.46) MEN1KMT2AGAATDP1MAOA
SCHEMBL1000860 0.98 MEN1 (0.46) MEN1KMT2AGAATDP1MAOA
SCHEMBL999017 0.98 MEN1 (0.46) MEN1KMT2AGAATDP1MAOA
SCHEMBL17906 0.90 MEN1 (0.52) MEN1KMT2AGAATDP1MAOA
Methane SCHEMBL1486197 0.88 MEN1 (0.50) MEN1KMT2AGAATDP1MAOA
Hydrochloric Acid SCHEMBL77819 0.88 MEN1 (0.50) MEN1KMT2AGAATDP1MAOA
Ammonia Solution, Strong SCHEMBL28788409 0.88 MEN1 (0.50) MEN1KMT2AGAATDP1MAOA
SCHEMBL9464092 0.88 MEN1 (0.50) MEN1KMT2AGAATDP1MAOA
SCHEMBL6679504 0.88 MEN1 (0.50) MEN1KMT2AGAATDP1MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0676471-B1 Effector proteins of rapamycin WYETH CORP (US) 2004-09-29 EP disclosed
US-20040157775-A1 Effector proteins of rapamycin WYETH 2004-08-12 US disclosed
US-6713607-B2 NUCLEOTIDE SEQUENCES CODING POLYPEPTIDE FOR USE IN THE TREATMENT OF RESTENOSIS AND TUMORS WYETH 2004-03-30 US disclosed
US-20030032775-A1 Effector proteins of rapamycin AMERICAN HOME PRODUCTS 2003-02-13 US disclosed
US-6313264-B1 POLYPEPTIDE; FOR USE IN TREATMENT OF SOLID TUMORS, LEUKEMIA,FUNGAL INFECTIONS, RESTENOSIS, ATHEROSCLEROSIS, AUTOIMMUNE AND INFLAMMATORY DISEASES AMERICAN HOME PRODUCTS CORPORATION 2001-11-06 US disclosed
EP-0676471-A2 Effector proteins of rapamycin AMERICAN HOME PRODUCTS CORPORATION (US) 1995-10-11 EP disclosed